# Japanese Dose-Response Study of Rimonabant in Obese Patients

> **NCT00459004** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 527 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** rimonabant (SR141716)

## Key facts

- **NCT ID:** NCT00459004
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 527 (ACTUAL)
- **Last updated:** 2009-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00459004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00459004, "Japanese Dose-Response Study of Rimonabant in Obese Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00459004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*